HOME >> BIOLOGY >> NEWS
Vaccine protects against fatal West Nile complication

A vaccine already approved in the United States to prevent a related disease protects experimental animals and may also protect people from the most serious complication associated with West Nile virus infection, say researchers from the University of Texas Medical Branch at Galveston (UTMB).

They report their findings today at the 50th Annual Meeting of the American Society of Tropical Medicine and Hygiene in Atlanta.

Dr. Robert Tesh, a professor in the Center for Tropical Diseases at UTMB and his colleagues tested two vaccines for Japanese encephalitis (JE) for their its ability to protect hamsters from the fatal encephalitis (inflammation of the brain) that is associated with West Nile viral infection.

The JE virus is a flavivirus, a member of the same viral family as the West Nile virus, dengue virus and St. Louis encephalitis virus.

"It looks like the West Nile virus is spreading throughout the Western Hemisphere and it will probably go all the way through the tropics and down to Argentina says Tesh.

In the United States we haven't had much exposure to flaviviruses; but we wanted to see what could happen when the West Nile virus reached an area like Central America where people have already had exposure to other flaviviruses, either through infection or vaccination.

Previous studies in India have suggested that prior infection with the JE virus will protect monkeys from fatal West Nile infections. In this study Tesh and his colleagues first inoculated hamsters with one of three flavivirus vaccines: a live-attenuated JE vaccine currently used on millions of people in China, a killed-virus JE vaccine currently approved for use in the United States and a yellow fever vaccine.

"If we infect hamsters with the New York strain of West Nile virus about half will die of encephalitis if they have not had a previous flavivirus infection," says Tesh. But in the case of the JE-vaccinated hamsters "none of them
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
14-Nov-2001


Page: 1 2

Related biology news :

1. Hope Clinic of Emory Vaccine Center receives CDC contract
2. Vaccines against foodborne disease on horizon
3. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
4. Vaccine technique shows potential against common form of lung cancer
5. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV
6. Emory Vaccine Research Center study identifies specific gene required for long-term immunity
7. Vaccine prevents stroke in rats
8. Vaccine puts blood-sucking ticks off their food
9. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
10. Vaccine controls AIDS in monkeys, researchers report in Science
11. Vaccine put into tomatoes shows promise fighting virus in lab tests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, ... on emerging technology, announces the availability of a new report, ... Continue Reading ... ... industrial and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, ...
(Date:1/26/2017)... -- Acuity Market Intelligence today released the 2017 "Ten ... characterizes 2017 as a "breakout" year for biometrics ... new understanding of the potential benefits these technologies ... are often perceived as threats to privacy and ... Acuity Market intelligence. "However, taken together these technologies ...
(Date:1/23/2017)... DENVER , Jan. 23, 2017  The latest ... biometric smartphone prices have dropped dramatically. The quarterly average ... Q1 2013 to $276 in Q4 2016.  There are ... average price of $116, up from just 28 a ... According to Maxine Most , Acuity ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... , Feb. 16, 2017   Biostage, Inc. ... "Company"), a biotechnology company developing bioengineered organ implants to ... bronchus and trachea, announced today the closing on February ... 20,000,000 shares of common stock and warrants to purchase ... of $8.0 million. The offering was priced at $0.40 ...
(Date:2/16/2017)... ... February 16, 2017 , ... AxioMed announced ... professor and Harvard trained surgeon, completed the procedure on Monday, Jan. 30 at ... practicing female physician suffering from degenerative disc disease with radiculomyelopathy, as a result ...
(Date:2/15/2017)... ... February 15, 2017 , ... Executive search firm, Slone ... with GenePeeks. Matt is a veteran life sciences and molecular diagnostics executive ... focused on identifying inherited disease risk in future generations. In his new role, ...
(Date:2/15/2017)... , Feb. 15, 2017 Windtree Therapeutics, ... company focused on developing aerosolized KL4 surfactant therapies ... completed a $10.5 million private placement of convertible ... has sufficient capital to fund its operations through ... data release in mid-2017. Windtree has ...
Breaking Biology Technology:
Cached News: